Sorry!! The article you are trying to read is not available now.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
XOMA (NQ: XOMA)
0.3518 USD  UNCHANGED
Last Price  /  Updated: 8:09 PM EDT, Oct 17, 2016  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 0.3518
Bid (Size) 0.3518 (2200)
Ask (Size) 0.3588 (1500)
Prev. Close 0.3518
Today's Range 0.3518 - 0.3518
52wk Range 0.3500 - 0.6988
Shares Outstanding 120,591,288
Dividend Yield N/A
Performance
YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
-36.04%
-36.04%
Top News
More News
XOMA Establishes Proof-of-Concept for 358 in Congenital Hyperinsulinism and Hypoglycemia Post-Bariatric Surgery
Congenital Hyperinsulinism Phase 2 study completed and multi-dose study protocol approved in the United Kingdom; Company initiates multi-dose study in hypoglycemic Post-Bariatric Surgery patients Read More
from GlobeNewswire News Releases
XOMA Announces up to $22 Million Generated from Sale of Royalty Streams from Two License Agreements to HealthCare Royalty Partners and Provides Corporate Update
XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced several corporate actions to further streamline its operations to focus on XOMA 358... Read More
from GlobeNewswire News Releases
More News
Read More
NetworkNewsBreaks – XOMA Corp. (NASDAQ: XOMA) Prices $25M Registered Offering; Shares Higher
category NetworkNewsWire Release , XOMA
from NetworkNewsWire
XOMA Announces Reverse Stock Split
from GlobeNewswire News Releases
XOMA Provides Update from Ongoing Phase 2 XOMA 358 Clinical Studies
from GlobeNewswire News Releases
XOMA to Host XOMA 358 Clinical Update Webcast and Conference Call on September 15, 2016
from GlobeNewswire News Releases
Biotech Stocks on Investors' Radar -- Illumina, XOMA, Lexicon Pharma, and VIVUS
from PR Newswire
XOMA to Present at the 2016 Wedbush PacGrow Healthcare Conference
from GlobeNewswire News Releases
12 Biggest Mid-Day Gainers For Tuesday
category XOMA , CFNL , XXIA , and 19 more.
from Benzinga
Xoma Corp Trading Well Above Recent Offering Price But Below October Reverse Split Levels
category Technicals , Intraday Update , Movers , and 3 more.
from Benzinga
XOMA Reports Second Quarter 2016 Achievements and Financial Results
from GlobeNewswire News Releases
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial

WHAT'S POPULAR IN THE VILLE

1
Bearish Wedge Pattern Signals Next Leg Lower On $MSFT
2
RV Eternabond Leak Repair
3
How Can You Get a Free Car Insurance Quote?
4
How about a coach day trips UK this summer
5
Why I Shorted Shares Of $TRV Here